Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis

被引：10

作者：

Kotyla, Przemyslaw J. ^{[1
]}

Sliwinska-Kotyla, Bogna ^{[1
]}

Kucharz, Eugene J. ^{[1
]}

机构：

[1] Med Univ Silecia, Dept Internal Med & Rheumatol, Katowice, Poland

来源：

CLINICAL RHEUMATOLOGY | 2007年 / 26卷 / 09期

关键词：

D O I：

10.1007/s10067-007-0657-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1595 / 1596

页数：2

共 8 条

[1] TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study [J].

Arnason, BGW ;

Jacobs, G ;

Hanlon, M ;

Clay, BH ;

Noronha, ABC ;

Auty, A ;

Davis, B ;

Nath, A ;

Bouchard, JP ;

Belanger, C ;

Gosselin, F ;

Thibault, M ;

Duquette, P ;

Bourgoin, P ;

DuBois, R ;

Girard, M ;

Ebers, GC ;

Rice, GPA ;

Vandervoort, MK ;

Francis, GS ;

Duncan, L ;

Lapierre, Y ;

Freedman, MS ;

Christie, SN ;

Rabinovitch, HE ;

Patry, D ;

Murphy, WF ;

Peters, S ;

McGuiness, SD ;

Murray, TJ ;

Bhan, V ;

Maxner, CE ;

Van Dorpe, R ;

Oger, JJ ;

Nelson, J ;

Morrison, W ;

Bogle, N ;

Beall, S ;

Vorobeychick, G ;

Hiltbrunner, AV ;

Bock, J ;

Habil ;

Lesslauer, W ;

Li, DKB ;

Paty, DW ;

Zhao, GJ .

NEUROLOGY, 1999, 53 (03) :457-465

[2]

Hoffman F. M., 1989, J EXP MED, V170, P607

[3]

Kotyla PJ, 2004, ANN RHEUM DIS, V63, P294

[4]

Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO

[5]

2-W

[6] ANTITUMOR NECROSIS FACTOR THERAPY ABROGATES AUTOIMMUNE DEMYELINATION [J].

SELMAJ, K ;

RAINE, CS ;

CROSS, AH .

ANNALS OF NEUROLOGY, 1991, 30 (05) :694-700

[7] ASSOCIATION BETWEEN TUMOR-NECROSIS-FACTOR-ALPHA AND DISEASE PROGRESSION IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].

SHARIEF, MK ;

HENTGES, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (07) :467-472

[8] Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment [J].

Tektonidou, Maria G. ;

Serelis, John ;

Skopouli, Fotini N. .

CLINICAL RHEUMATOLOGY, 2007, 26 (02) :258-260

← 1 →